RESUMEN
Hypocalcaemia is a common cause of neonatal seizures. Here, we present a breastfed neonate with smooth perinatal transition and no family history of seizures presenting at 3 weeks with recurrent multifocal clonic seizures. On evaluation, the neonate was found to have low iCa and total calcium. 25-hydroxy vitamin D (25(OH)D) level was low and intact parathyroid hormone (iPTH) was inappropriately normal. The maternal evaluation revealed high calcium and low phosphate levels. iPTH was very high and 25(OH)D was very low in the mother. Sestamibi scan showed a left inferior parathyroid adenoma in the mother. Maternal primary hyperparathyroidism causing hypercalcaemia can suppress parathyroid activity in the fetus, resulting in inappropriate parathyroid response to hypocalcaemia after birth causing recurrent hypocalcaemic seizures. So neonatal hypocalcaemic seizures need careful evaluation of the neonate and the mother at times and can help both mother and neonate.
Asunto(s)
Hipercalcemia , Hiperparatiroidismo Primario , Hipocalcemia , Embarazo , Femenino , Recién Nacido , Humanos , Hipocalcemia/complicaciones , Hipocalcemia/diagnóstico , Calcio , Hiperparatiroidismo Primario/complicaciones , Hiperparatiroidismo Primario/diagnóstico , Hormona Paratiroidea , Hipercalcemia/etiología , Hipercalcemia/complicaciones , Convulsiones/etiologíaRESUMEN
Colchicine, one of the oldest anti-inflammatory natural products still used clinically, inhibits NF-κB signaling and NLRP3 inflammasome activation. Despite its cytotoxicity and narrow therapeutic range, colchicine continues to intrigue medicinal chemists exploring its anti-inflammatory potential. This study aimed to investigate the colchicine scaffold for its role in Alzheimer's disease by targeting neuroinflammation and cholinesterases. Molecular docking revealed that colchicine's hydrophobic trimethoxyphenyl framework can potentially bind to the peripheral anionic site of cholinesterases. Hybrid structures combining colchicine with aryl/alkyl amines were designed to bind both peripheral and catalytic sites of cholinesterases. We describe here the design, synthesis, and in vitro cytotoxicity evaluation of these colchicine-aryl/alkyl amine hybrids, along with their in silico interactions with the cholinesterase active site gorge. Nontoxic analogs demonstrating strong cholinesterase binding affinity were further evaluated for their anticholinesterase and antineuroinflammatory activities. The colchicine-donepezil hybrid, SBN-284 (3x), inhibited both acetylcholinesterase and butyrylcholinesterase as well as the NLRP3 inflammasome complex at low micromolar concentrations. It achieved this through noncompetitive inhibition, occupying the active site gorge and interacting with both peripheral and catalytic anionic sites of cholinesterases. Analog 3x was shown to cross the blood-brain barrier and exhibited no toxicity to neuronal cells, primary macrophages, or epithelial fR2 cells. These findings highlight the potential of this lead compound for further preclinical investigation as a promising anti-Alzheimer agent.
Asunto(s)
Inhibidores de la Colinesterasa , Colchicina , Inflamasomas , Simulación del Acoplamiento Molecular , Proteína con Dominio Pirina 3 de la Familia NLR , Colchicina/farmacología , Inhibidores de la Colinesterasa/farmacología , Inhibidores de la Colinesterasa/síntesis química , Inhibidores de la Colinesterasa/química , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/antagonistas & inhibidores , Animales , Inflamasomas/metabolismo , Humanos , Ratones , Aminas/farmacología , Aminas/química , Donepezilo/farmacología , Piperidinas/farmacología , Piperidinas/químicaRESUMEN
Aim: The study is conducted to explore various expectations of patients with malocclusion from Orthodontic treatment. Material and Methods: A cross-sectional questionnaire survey was conducted among 350 Patients with malocclusion seeking Orthodontic treatment in various private clinics of Jodhpur city. Questionnaire consists of three parts assessing the expectation of patients from Orthodontic treatment. Results: Majority of study participants {211(60%)} belongs to age group of 16-19 years. Among all study participants 248 (71%) were females. Majority of study participants {233(67%)} expects there Orthodontic treatment duration to be 1-2 years. 148(42%) of study participants expects their Orthodontic treatment to be very traumatic while 134(38%) of study participants expects very less side effects from Orthodontic treatment. Majority of Study participants {189(54%)} expects an excellent improvement from Orthodontic treatment. Attitude of orthodontist was positive for 175 (50%) study participants. Conclusions: Expectation of the patients towards Orthodontic treatment and Orthodontist were positive and are satisfied about their treatment. Most of the patients had realistic expectations regarding their Orthodontic treatment which can be fulfilled by the Orthodontists.